Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
The EU's Anti-Coercion Instrument could limit access to public tenders in the bloc or restrict trade in services in which the U.S. has a surplus with the EU. A draft charter sent to about 60 countries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback